SUCCINYLCHOLINE CHLORIDE

N/A

Manufactured by Hospira, Inc.

4,806 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SUCCINYLCHOLINE CHLORIDE

SUCCINYLCHOLINE CHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Hospira, Inc.. The most commonly reported adverse reactions for SUCCINYLCHOLINE CHLORIDE include DRUG INEFFECTIVE, HYPOTENSION, CARDIAC ARREST, ANAPHYLACTIC SHOCK, RENAL FAILURE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SUCCINYLCHOLINE CHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE289 reports
HYPOTENSION177 reports
CARDIAC ARREST164 reports
ANAPHYLACTIC SHOCK140 reports
RENAL FAILURE120 reports
DRUG INTERACTION119 reports
PAIN117 reports
ANAPHYLACTIC REACTION111 reports
ANXIETY105 reports
RENAL IMPAIRMENT104 reports
INJURY101 reports
UNEVALUABLE EVENT93 reports
HYPERTHERMIA MALIGNANT92 reports
MATERNAL EXPOSURE DURING PREGNANCY90 reports
EMOTIONAL DISTRESS89 reports
FEAR87 reports
DEATH85 reports
BRADYCARDIA74 reports
RENAL INJURY73 reports
RHABDOMYOLYSIS73 reports
ANHEDONIA67 reports
STRESS62 reports
FOETAL EXPOSURE DURING PREGNANCY61 reports
DRUG HYPERSENSITIVITY59 reports
VENTRICULAR TACHYCARDIA59 reports
MULTI ORGAN FAILURE55 reports
HYPERKALAEMIA53 reports
BRONCHOSPASM51 reports
HYPOXIA47 reports
OFF LABEL USE47 reports
TACHYCARDIA46 reports
EXPOSURE DURING PREGNANCY44 reports
SEROTONIN SYNDROME43 reports
APNOEA42 reports
DRUG EXPOSURE DURING PREGNANCY42 reports
RESPIRATORY FAILURE42 reports
LOSS OF CONSCIOUSNESS40 reports
DEPRESSION38 reports
PREMATURE BABY38 reports
SEIZURE38 reports
CARDIO RESPIRATORY ARREST35 reports
DIABETES INSIPIDUS35 reports
LEFT VENTRICULAR DYSFUNCTION35 reports
FOETAL DEATH34 reports
METABOLIC ACIDOSIS34 reports
POST PROCEDURAL COMPLICATION34 reports
PULMONARY OEDEMA34 reports
NEUROMUSCULAR BLOCK PROLONGED33 reports
RENAL FAILURE ACUTE33 reports
CONDITION AGGRAVATED32 reports
OXYGEN SATURATION DECREASED32 reports
UNRESPONSIVE TO STIMULI32 reports
BLOOD PRESSURE DECREASED31 reports
BLOOD CALCIUM DECREASED30 reports
ENCEPHALOPATHY30 reports
ERYTHEMA30 reports
PARALYSIS30 reports
PYREXIA30 reports
BLOOD PH DECREASED29 reports
PCO2 INCREASED29 reports
ANAESTHETIC COMPLICATION28 reports
BLOOD MAGNESIUM DECREASED28 reports
DYSPNOEA28 reports
MUSCLE RIGIDITY28 reports
MYALGIA28 reports
OXYGEN SATURATION ABNORMAL27 reports
BLOOD BICARBONATE DECREASED26 reports
RASH26 reports
RENAL ISCHAEMIA26 reports
TOXICITY TO VARIOUS AGENTS26 reports
CONVULSION25 reports
VENTRICULAR FIBRILLATION25 reports
DEPRESSED LEVEL OF CONSCIOUSNESS24 reports
OVERDOSE24 reports
PSEUDOCHOLINESTERASE DEFICIENCY24 reports
STATUS EPILEPTICUS24 reports
CAESAREAN SECTION23 reports
HYPERTENSION23 reports
MATERNAL EXPOSURE DURING DELIVERY23 reports
PRODUCT QUALITY ISSUE23 reports
BLOOD CREATINE PHOSPHOKINASE INCREASED22 reports
CIRCULATORY COLLAPSE22 reports
PO2 INCREASED22 reports
ACUTE KIDNEY INJURY20 reports
HYPERSENSITIVITY20 reports
RESPIRATORY DEPRESSION20 reports
ELECTROCARDIOGRAM ST SEGMENT ELEVATION19 reports
HEART RATE INCREASED19 reports
PREMATURE LABOUR19 reports
SINUS BRADYCARDIA19 reports
BLOOD CREATININE INCREASED18 reports
DELAYED RECOVERY FROM ANAESTHESIA18 reports
HYPOTONIA18 reports
MYOCARDIAL INFARCTION18 reports
PRODUCT USE IN UNAPPROVED INDICATION18 reports
TACHYPNOEA18 reports
ASTHENIA17 reports
CEREBROVASCULAR ACCIDENT17 reports
COMA17 reports
MUSCULAR WEAKNESS17 reports

Report Outcomes

Out of 2,160 classified reports for SUCCINYLCHOLINE CHLORIDE:

Serious 82.7%Non-Serious 17.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,017 (56.3%)
Male760 (42.1%)
Unknown28 (1.6%)

Reports by Age

Age 3160 reports
Age 5745 reports
Age 3238 reports
Age 5837 reports
Age 5236 reports
Age 7036 reports
Age 4435 reports
Age 3334 reports
Age 4134 reports
Age 5332 reports
Age 4831 reports
Age 4930 reports
Age 6729 reports
Age 2528 reports
Age 2728 reports
Age 4628 reports
Age 6228 reports
Age 6928 reports
Age 2927 reports
Age 3727 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SUCCINYLCHOLINE CHLORIDE?

This profile reflects 4,806 FDA FAERS reports that mention SUCCINYLCHOLINE CHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SUCCINYLCHOLINE CHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HYPOTENSION, CARDIAC ARREST, ANAPHYLACTIC SHOCK, RENAL FAILURE, DRUG INTERACTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SUCCINYLCHOLINE CHLORIDE?

Labeling and FAERS entries often list Hospira, Inc. in connection with SUCCINYLCHOLINE CHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.